Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | alpha-galactosidase/alpha-N-acetylgalactosaminidase, putative | 0.0068 | 0.1647 | 1 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0022 | 0.0184 | 0.009 |
Giardia lamblia | Ubiquitin carboxyl-terminal hydrolase 4 | 0.0026 | 0.0308 | 0.5 |
Schistosoma mansoni | lipoxygenase | 0.0082 | 0.2099 | 0.6387 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0117 | 0.3232 | 0.3167 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0043 | 0.0848 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0022 | 0.0184 | 0.0283 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0043 | 0.0848 | 0.0761 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0068 | 0.1647 | 0.4946 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0068 | 0.165 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.0184 | 0.0896 |
Leishmania major | trypanothione reductase | 0.0027 | 0.0327 | 0.1669 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0024 | 0.0222 | 0.2342 |
Echinococcus multilocularis | neuropeptide s receptor | 0.0327 | 1 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0071 | 0.1736 | 1 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0024 | 0.0222 | 0.1347 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.0095 | 0.0375 |
Mycobacterium ulcerans | hypothetical protein | 0.0024 | 0.0222 | 0.2342 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0024 | 0.0222 | 0.2342 |
Plasmodium vivax | multidomain scavenger receptor, putative | 0.002 | 0.0095 | 0.216 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0061 | 0.1431 | 0.8671 |
Echinococcus multilocularis | GPCR, family 2 | 0.0022 | 0.0184 | 0.009 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0068 | 0.1647 | 0.4946 |
Echinococcus multilocularis | ubiquitin carboxyl terminal hydrolase 8 | 0.0026 | 0.0308 | 0.0215 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0022 | 0.0184 | 0.0542 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0043 | 0.0848 | 0.5141 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0024 | 0.0222 | 0.2342 |
Echinococcus multilocularis | ubiquitin specific protease 41 | 0.0026 | 0.0308 | 0.0215 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0043 | 0.0848 | 0.2402 |
Echinococcus granulosus | Peptidase C19 ubiquitin carboxyl terminal hydrolase 2 | 0.0026 | 0.0308 | 0.0215 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0222 | 0.1122 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0027 | 0.0327 | 0.1735 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0043 | 0.0848 | 0.0761 |
Brugia malayi | AMP-binding enzyme family protein | 0.0024 | 0.0222 | 0.0777 |
Schistosoma mansoni | ubiquitin-specific peptidase 2 (C19 family) | 0.0026 | 0.0308 | 0.0678 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.1018 | 0.5786 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.0095 | 0.0375 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0061 | 0.1431 | 0.8671 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0043 | 0.0848 | 0.2164 |
Echinococcus granulosus | ubiquitin specific protease 41 | 0.0026 | 0.0308 | 0.0215 |
Mycobacterium leprae | PROBABLE NADH DEHYDROGENASE NDH | 0.0061 | 0.1431 | 0.8464 |
Echinococcus multilocularis | Peptidase C19, ubiquitin carboxyl terminal hydrolase 2 | 0.0026 | 0.0308 | 0.0215 |
Trypanosoma brucei | trypanothione reductase | 0.0027 | 0.0327 | 1 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0024 | 0.0222 | 0.1347 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0061 | 0.1431 | 0.8671 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0048 | 0.1018 | 0.5622 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0061 | 0.1431 | 0.8671 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0022 | 0.0184 | 0.0896 |
Loa Loa (eye worm) | doublecortin family protein | 0.002 | 0.0095 | 0.0375 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0022 | 0.0184 | 0.009 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0024 | 0.0222 | 0.2342 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0102 | 0.2737 | 0.8421 |
Brugia malayi | Melibiase family protein | 0.0068 | 0.1647 | 0.9454 |
Echinococcus granulosus | GPCR family 2 | 0.0022 | 0.0184 | 0.009 |
Schistosoma mansoni | hypothetical protein | 0.0022 | 0.0184 | 0.0283 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0102 | 0.2737 | 0.8421 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0043 | 0.0848 | 1 |
Mycobacterium tuberculosis | Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) | 0.0018 | 0.0031 | 0.0187 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0027 | 0.0327 | 0.1981 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0027 | 0.0327 | 1 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0024 | 0.0222 | 0.2342 |
Schistosoma mansoni | ubiquitin-specific peptidase 8 (C19 family) | 0.0026 | 0.0308 | 0.0678 |
Echinococcus multilocularis | neuropeptide receptor A26 | 0.0327 | 1 | 1 |
Loa Loa (eye worm) | glutathione reductase | 0.0027 | 0.0327 | 0.1735 |
Brugia malayi | AMP-binding enzyme family protein | 0.0024 | 0.0222 | 0.0777 |
Brugia malayi | Thioredoxin reductase | 0.0027 | 0.0327 | 0.1413 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0043 | 0.0848 | 1 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0022 | 0.0184 | 0.009 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0068 | 0.165 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0222 | 0.1122 |
Schistosoma mansoni | hypothetical protein | 0.0048 | 0.1018 | 0.2942 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0102 | 0.2737 | 0.8421 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0022 | 0.0184 | 0.009 |
Plasmodium falciparum | glutathione reductase | 0.0027 | 0.0327 | 1 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0061 | 0.1431 | 0.8671 |
Schistosoma mansoni | hypothetical protein | 0.0022 | 0.0184 | 0.0283 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0027 | 0.0338 | 0.0246 |
Schistosoma mansoni | lipoxygenase | 0.0117 | 0.3232 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0071 | 0.1736 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0308 | 0.1622 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0022 | 0.0184 | 0.0542 |
Loa Loa (eye worm) | hypothetical protein | 0.0068 | 0.1647 | 0.9474 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0027 | 0.0327 | 1 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0102 | 0.2737 | 0.8421 |
Echinococcus granulosus | neuropeptide receptor A26 | 0.0327 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0071 | 0.1736 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0222 | 0.1122 |
Brugia malayi | AMP-binding enzyme family protein | 0.0024 | 0.0222 | 0.0777 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0068 | 0.165 | 1 |
Leishmania major | ubiquitin hydrolase, putative,cysteine peptidase, Clan CA, family C19, putative | 0.0026 | 0.0308 | 0.1361 |
Echinococcus multilocularis | Glycoside hydrolase, family 27 | 0.0102 | 0.2737 | 0.2667 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0024 | 0.0222 | 0.2342 |
Onchocerca volvulus | 0.0024 | 0.0222 | 1 | |
Plasmodium falciparum | LCCL domain-containing protein | 0.002 | 0.0095 | 0.216 |
Mycobacterium tuberculosis | Probable reductase | 0.0061 | 0.1431 | 0.8671 |
Echinococcus granulosus | Alpha N acetylgalactosaminidase | 0.0102 | 0.2737 | 0.2667 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0068 | 0.165 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0043 | 0.0848 | 1 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0027 | 0.0338 | 0.0246 |
Chlamydia trachomatis | acylglycerophosphoethanolamine acyltransferase | 0.0018 | 0.0031 | 0.5 |
Plasmodium vivax | glutathione reductase, putative | 0.0027 | 0.0327 | 1 |
Entamoeba histolytica | ubiquitin carboxyl-terminal hydrolase domain containing protein | 0.0026 | 0.0308 | 1 |
Echinococcus multilocularis | Alpha N acetylgalactosaminidase | 0.0102 | 0.2737 | 0.2667 |
Toxoplasma gondii | melibiase subfamily protein | 0.0102 | 0.2737 | 1 |
Plasmodium falciparum | thioredoxin reductase | 0.0027 | 0.0327 | 1 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0024 | 0.0222 | 0.2342 |
Schistosoma mansoni | hypothetical protein | 0.0022 | 0.0184 | 0.0283 |
Brugia malayi | Ubiquitin carboxyl-terminal hydrolase family protein | 0.0026 | 0.0308 | 0.1296 |
Brugia malayi | glutathione reductase | 0.0027 | 0.0327 | 0.1413 |
Echinococcus granulosus | ubiquitin carboxyl terminal hydrolase 8 | 0.0026 | 0.0308 | 0.0215 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0043 | 0.0848 | 0.2402 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0117 | 0.3232 | 0.3167 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0071 | 0.1736 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.